Lifevantage expects full-year earnings in the range of 72 cents to 88 cents per share, with revenue in the range of $235 million to $245 million. This story was generated by Automated Insights ( http: ...
In such a dynamic environment, identifying promising small-cap stocks like LifeVantage can offer unique opportunities for investors seeking growth potential beyond well-trodden paths.
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy recommendation. Analyst Price Forecast Suggests 3.07% Upside As of December 23 ...
LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...
Lake Street analyst Brooks O’Neil initiated coverage of LifeVantage (LFVN) with a Buy rating and $26 price target The company’s products activate physical wellness by using science-based ...
SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a ...